|
Bilson, J., Sethi, J. K., & Byrne, C. D. (2022). Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function. Proceedings of the Nutrition Society, 81(2), 146–161.
Grove, J. I., Lo, P. C. K., Shrine, N., Barwell, J., Wain, L. V., Tobin, M. D., Salter, A. M., Borkar, A. N., Cuevas-Ocaña, S., Bennett, N., John, C., Ntalla, I., Jones, G. E., Neal, C. P., Thomas, M. G., Kuht, H., Gupta, P., Vemala, V. M., Grant, A., … Aithal, G. P. (2023). Identification and characterisation of a rare MTTP variant underlying hereditary non-alcoholic fatty liver disease. JHEP Reports, 5(8), 100764.
Hannan, Nicholas R F, Segeritz, C.-P., Touboul, T., & Vallier, L. (2013). Production of hepatocyte-like cells from human pluripotent stem cells. Nature Protocols, 8(2), 430–437.
Harrington, H., Cato, P., Salazar, F., Wilkinson, M., Knox, A., Haycock, J. W., Rose, F., Aylott, J. W., & Ghaemmaghami, A. M. (2014). Immunocompetent 3D Model of Human Upper Airway for Disease Modeling and In Vitro Drug Evaluation. Molecular Pharmaceutics, 11(7), 2082–2091. https://doi.org/10.1021/mp5000295
Huang, D., Liu, T., Liao, J., Maharjan, S., Xie, X., Pérez, M., Anaya, I., Wang, S., Tirado Mayer, A., Kang, Z., Kong, W., Mainardi, V. L., Garciamendez-Mijares, C. E., García Martínez, G., Moretti, M., Zhang, W., Gu, Z., Ghaemmaghami, A. M., & Zhang, Y. S. (2021). Reversed-engineered human alveolar lung-on-a-chip model. Proceedings of the National Academy of Sciences, 118(19), e2016146118. https://doi.org/10.1073/pnas.2016146118
Isaacs-Ten, A., Moreno-Gonzalez, M., Bone, C., Martens, A., Bernuzzi, F., Ludwig, T., Hellmich, C., Hiller, K., Rushworth, S. A., & Beraza, N. (2022). Metabolic Regulation of Macrophages by SIRT1 Determines Activation During Cholestatic Liver Disease in Mice. Cellular and Molecular Gastroenterology and Hepatology, 13(4), 1019–1039. https://doi.org/https://doi.org/10.1016/j.jcmgh.2021.12.010
Jiang, N., Ying, G., Yin, Y., Guo, J., Lozada, J., Valdivia Padilla, A., Gómez, A., Gomes de Melo, B. A., Lugo Mestre, F., Gansevoort, M., Palumbo, M., Calá, N., Garciamendez-Mijares, C. E., Kim, G.-A., Takayama, S., Gerhard-Herman, M. D., & Zhang, Y. S. (2024). A closed-loop modular multiorgan-on-chips platform for self-sustaining and tightly controlled oxygenation. Proceedings of the National Academy of Sciences, 121(47), e2413684121. https://doi.org/10.1073/pnas.2413684121
Kendall, T. J., Jimenez-Ramos, M., Turner, F., Ramachandran, P., Minnier, J., McColgan, M. D., Alam, M., Ellis, H., Dunbar, D. R., Kohnen, G., Konanahalli, P., Oien, K. A., Bandiera, L., Menolascina, F., Juncker-Jensen, A., Alexander, D., Mayor, C., Guha, I. N., & Fallowfield, J. A. (2023). An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease. Nature Medicine, 29(11), 2939–2953. https://doi.org/10.1038/s41591-023-02602-2
Koido, M., Kawakami, E., Fukumura, J., Noguchi, Y., Ohori, M., Nio, Y., Nicoletti, P., Aithal, G. P., Daly, A. K., Watkins, P. B., Anayama, H., Dragan, Y., Shinozawa, T., & Takebe, T. (2020). Polygenic architecture informs potential vulnerability to drug-induced liver injury. Nature Medicine, 26(10), 1541–1548. https://doi.org/10.1038/s41591-020-1023-0
Moreno-Gonzalez, M., Hampton, K., Ruiz, P., Beasy, G., Nagies, F. S. P., Parker, A., Lazenby, J., Bone, C., Alava-Arteaga, A., Patel, M., Hellmich, C., Luri-Martin, P., Silan, E., Philo, M., Baker, D., Rushbrook, S. M., Hildebrand, F., Rushworth, S. A., & Beraza, N. (2024). Regulation of intestinal senescence during cholestatic liver disease modulates barrier function and liver disease progression. JHEP Reports, 6(10), 101159. https://doi.org/https://doi.org/10.1016/j.jhepr.2024.101159
Osuna de la Peña, D., Trabulo, S. M. D., Collin, E., Liu, Y., Sharma, S., Tatari, M., Behrens, D., Erkan, M., Lawlor, R. T., Scarpa, A., Heeschen, C., Mata, A., & Loessner, D. (2021). Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology. Nature Communications, 12(1), 5623. https://doi.org/10.1038/s41467-021-25921-9
Patel, M. N., Bernard, W. G., Milev, N. B., Cawthorn, W. P., Figg, N., Hart, D., Prieur, X., Virtue, S., Hegyi, K., Bonnafous, S., Bailly-Maitre, B., Chu, Y., Griffin, J. L., Mallat, Z., Considine, R. V, Tran, A., Gual, P., Takeuchi, O., Akira, S., … Sethi, J. K. (2015). Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation. Proceedings of the National Academy of Sciences, 112(2), 506–511. https://doi.org/10.1073/pnas.1414536112
Ramachandran, P., Brice, M., Sutherland, E. F., Hoy, A. M., Papachristoforou, E., Jia, L., Turner, F., Kendall, T. J., Marwick, J. A., Carragher, N. O., Oro, D., Feigh, M., Leeming, D. J., Nielsen, M. J., Karsdal, M. A., Hartmann, N., Erickson, M., Adorini, L., Roth, J. D., & Fallowfield, J. A. (2024). Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767. Hepatology Communications, 8(12).
Sampaziotis, F., Cardoso de Brito, M., Madrigal, P., Bertero, A., Saeb-Parsy, K., Soares, F. A. C., Schrumpf, E., Melum, E., Karlsen, T. H., Bradley, J. A., Gelson, W. T. H., Davies, S., Baker, A., Kaser, A., Alexander, G. J., Hannan, N. R. F., & Vallier, L. (2015). Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nature Biotechnology, 33(8), 845–852. https://doi.org/10.1038/nbt.3275
Sampaziotis, F., de Brito, M. C., Geti, I., Bertero, A., Hannan, N. R. F., & Vallier, L. (2017). Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells. Nature Protocols, 12(4), 814–827. https://doi.org/10.1038/nprot.2017.011
Scorletti, E., Afolabi, P. R., Miles, E. A., Smith, D. E., Almehmadi, A., Alshathry, A., Childs, C. E., Del Fabbro, S., Bilson, J., Moyses, H. E., Clough, G. F., Sethi, J. K., Patel, J., Wright, M., Breen, D. J., Peebles, C., Darekar, A., Aspinall, R., Fowell, A. J., … Byrne, C. D. (2020). Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology, 158(6), 1597-1610.e7. https://doi.org/https://doi.org/10.1053/j.gastro.2020.01.031
Sharifi, F., Htwe, S. S., Righi, M., Liu, H., Pietralunga, A., Yesil-Celiktas, O., Maharjan, S., Cha, B.-H., Shin, S. R., Dokmeci, M. R., Vrana, N. E., Ghaemmaghami, A. M., Khademhosseini, A., & Zhang, Y. S. (2019). A Foreign Body Response-on-a-Chip Platform. Advanced Healthcare Materials, 8(4), 1801425. https://doi.org/https://doi.org/10.1002/adhm.201801425
Zhang, Y. S., Aleman, J., Shin, S. R., Kilic, T., Kim, D., Mousavi Shaegh, S. A., Massa, S., Riahi, R., Chae, S., Hu, N., Avci, H., Zhang, W., Silvestri, A., Sanati Nezhad, A., Manbohi, A., De Ferrari, F., Polini, A., Calzone, G., Shaikh, N., … Khademhosseini, A. (2017). Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proceedings of the National Academy of Sciences, 114(12), E2293–E2302. https://doi.org/10.1073/pnas.1612906114
|